Advertisement

Index by author

May 01, 1995; Volume 47,Issue 5

  1. Labbe-jullie, C

    1. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
      C Labbé-Jullié, J M Botto, M V Mas, J Chabry, J Mazella, J P Vincent, D Gully, J P Maffrand and P Kitabgi
      Molecular Pharmacology May 1995, 47 (5) 1050-1056;

  2. Larsen, A K

    1. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
      S Lelièvre, Y Benchokroun and A K Larsen
      Molecular Pharmacology May 1995, 47 (5) 898-906;
    2. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.
      H M Beere, C M Chresta, A Alejo-Herberg, A Skladanowski, C Dive, A K Larsen and J A Hickman
      Molecular Pharmacology May 1995, 47 (5) 986-996;

  3. Law, P Y

    1. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
      E T Piros, P L Prather, H H Loh, P Y Law, C J Evans and T G Hales
      Molecular Pharmacology May 1995, 47 (5) 1041-1049;

  4. Leanza, G

    1. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide.
      A Copani, V Bruno, G Battaglia, G Leanza, R Pellitteri, A Russo, S Stanzani and F Nicoletti
      Molecular Pharmacology May 1995, 47 (5) 890-897;

  5. Lelievre, S

    1. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
      S Lelièvre, Y Benchokroun and A K Larsen
      Molecular Pharmacology May 1995, 47 (5) 898-906;

  6. Lewis, A D

    1. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
      S Chen, R Knox, A D Lewis, F Friedlos, P Workman, P S Deng, M Fung, D Ebenstein, K Wu and T M Tsai
      Molecular Pharmacology May 1995, 47 (5) 934-939;

  7. Li, L

    1. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
      L Y Yang, L Li, M J Keating and W Plunkett
      Molecular Pharmacology May 1995, 47 (5) 1072-1079;

  8. Loh, H H

    1. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
      E T Piros, P L Prather, H H Loh, P Y Law, C J Evans and T G Hales
      Molecular Pharmacology May 1995, 47 (5) 1041-1049;
Back to top

In this issue

Advertisement